focus -WSS

focus

author：fashion 2025-09-06 03:50:54 - browse：67

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Congress must give Medicare recipients genetic counseling access

WSS

How medical schools plan to diversify without affirmative action

Clinical trials must include more disabled people

FDA panel endorses Alnylam’s heart drug — after picking it apart

New definition of a human embryo proposed amid rapid advances

New details revealed about Purdue's marketing of OxyContin

Beware the threat of staffing cuts at the CDC

focus

focus

leisure time

How to save PrEP access — and even expand it

Walmart eyes Medicare Advantage provider ChenMed

Affirmative action in medical school literally saved lives

Trump's false claims about Georgia's 2020 election long debunked

Affirmative action in medical school literally saved lives

Acelyrin, a rare IPO success, stumbles in its first big test

Continuity nursing helped my family in our darkest PICU moments

ProMED sees offers of support, but its future remains unclear

Jerome Adams on the need for new antivirals for Covid

Regeneron agrees to White House price limits on anti

Wikipedia

How to make the FDA’s new prescription one

Living with Hashimoto's and celiac disease, and med school, too

Hilary expected to bring catastrophic, life

Congress must give Medicare recipients genetic counseling access

Eye stem cell transplant could help restore vision in injured people

FDA panel endorses Alnylam’s heart drug — after picking it apart

focus

focus

explore

leisure time